期刊文献+

Skp2与其底物CDKN1B(p27)在结直肠癌中的作用 被引量:6

下载PDF
导出
摘要 结直肠癌(colorectal cancer,CRC)是全球高发恶性肿瘤之一,居癌症患者致死第4位。对结直肠癌的发生、发展中的信号通路和与之相关的细胞因子的相关研究较多。S期激酶相关蛋白2(S-phase kinase-associated protein 2,Skp2)的过表达在结直肠癌的发生与发展的过程中扮演至关重要的角色。F-box蛋白Skp2是Skp1-Cullin 1-F-box(SCF)泛素连接酶(E3)复合物的组成元件,具有调节细胞增殖的作用,同时能通过调控多种细胞周期的泛素化和26S蛋白酶体降解来调控肿瘤细胞的进展与转移。Skp2与其蛋白基质细胞周期蛋白依赖性激酶抑制剂1B(cyclin-dependent kinase inhibitor 1B,CDKN1B),也被称为p27kip1间通过SCF-Skp2复合体和细胞周期蛋白依赖性激酶亚基1(cyclin-dependent kinase subunit 1,Cks1)辅因子的激活而进行有效的链接。Skp2的过表达、Cks1和CDKN1B(p27)表达的变化对结直肠癌的发生、发展起到重要的作用,三者可能是结直肠癌独立的预后指标。Skp2可能是结直肠癌治疗中有前景的靶标,其抑制剂的研发对结直肠癌的治疗起关键性作用。本文将对Skp2与其泛素-蛋白酶体途径在结直肠癌中的作用进行综述。
出处 《实用肿瘤杂志》 CAS 2016年第5期478-482,共5页 Journal of Practical Oncology
  • 相关文献

参考文献27

  • 1Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer inci- dence and mortality worldwide:sources, methods and ma- jor patterns in GLOBOCAN 2012 [ J ]. Int J Cancer,2015, 136(5) :E359 -386.
  • 2Derwinger K, Kodeda K, Gerjy R. Age aspects of demogra- phy,pathology and survival assessment in colorectal canc-er[J]. Anticancer Res,2010,30(12) :5227 -5231.
  • 3Bonfrate L,Ahomare DF, Di Lena M, et al. MicroRNA in colorectal cancer: new perspectives for diagnosis, progno- sis and treatment[ J]. J Gastrointestin Liver Dis,2013,22 (3) :311 -320.
  • 4Hershko DD, Shapira M. Prognostic role of p27 ( Kipl ) deregulation in colorectal cancer [ J ]. Cancer, 2006, 107 (4) :668 - 675.
  • 5Frescas D, Pagano M. Deregulated proteolysis by the F- box proteins SKP2 and beta-TrCP-tipping the scales of cancer [ J ]. Nat Rev Cancer, 2008,8 (6):438 - 449.
  • 6Wang Z, Gao D, Fukushima H, et al. Skp2 :A novel poten- tial therapeutic target for prostate cancer [ J ]. Biochim Biophys Acta,2012,1825 ( 1 ) : 11 - 17.
  • 7He W, Wang X, Chen L, et al. A crosstalk imbalance be- tween p27 (Kipl) and its interacting molecules enhances breast carcinogenesis [ J ]. Cancer Biother Radiopharm, 2012,27(7) :399 -402.
  • 8Tian YF, Chen TJ, Lin CY, et al. SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic tar- get with high potential [ J ]. Tumor Biol, 2013,34 (2) : 1107 - 1117.
  • 9Hoellein A, Graf S, Bassermann F, et al. Cksl promotion of S phase entry and proliferation is independent of p27(Kipl) suppression [ J]. Mol Cell Biol, 2012, 32 ( 13 ) :2416 - 2427.
  • 10Nakayama KI, Nakayama K. Ubiquitin ligases : cell-cycle control and cancer [ J ]. Nat Rev Cancer, 2006,6 ( 5 ) : 369 - 381.

二级参考文献32

  • 1马秀梅,刘江惠,郭建文,刘颖,左连富.胃癌组织Skp2表达的意义及与p27表达的关系[J].实用肿瘤杂志,2006,21(1):24-28. 被引量:3
  • 2王力,余子健,马艳.结直肠癌P27蛋白表达及其意义[J].南华大学学报(医学版),2007,35(2):227-229. 被引量:2
  • 3Philipp-Staheli J,Payne SR,Kemp CJ.p27(Kip1):regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer [J].Exp Cell Res,2001,264(1):148-168.
  • 4Pagano M,Tam SW,Theodoras AM,et al.Role of the ubiquitin-proteasome,pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [J].Science (Wash.DC),1995,269(5224):682-685.
  • 5Tsvetkov LM,Yeh KH,Lee SJ,et al.p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27 [J].Curr Biol,1999,9(12):661-664.
  • 6Kudo Y,Kitajima S,Sato S,et al.High expression of S-phase kinase-interacting protein 2,human F-box protein,correlates with poor prognosis in oral squamous cell carcinomas [J].Cancer Res,2001,61(19):7044-7047.
  • 7Gstaiger M,Jordan R,Lim M,et al.Skp2 is oncogenic and overexpressed in human cancers [J].Proc Natl Acad Sci USA,2001,98(9):5043-5048.
  • 8Signoretti S,Di Marcotullio L,Richardson A,et al.Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer [J].J Clin Invest,2002,110(5):633-641.
  • 9Li JQ,Wu F,Masaki T,et al.Correlation of Skp2 with carcinogenesis,invasion,metastasis,and prognosis in colorectal tumors [J].Int J Oncol,2004,25(1):87-95.
  • 10Yokoi S,Yasui K,Mori M,et al.Amplification and overexpression of Skp2 are associated with metastasis of non-small cell lung cancers to lymph nodes [J].Am J Pathol,2004,165(1):175-180.

共引文献4

同被引文献47

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部